Deals

The buyout firm had moved Curium Pharma into a €1.2bn single-asset continuation fund in 2020.

The firm is understood to be running a process to move the vegetation management services company out of its $934m Fund IV and into a new vehicle.

CVs of CVs have become a popular tool to maintain control of trophy assets, with several processes launching this year.

The transaction involves a continuation fund-like structure, Secondaries Investor understands, and includes an option for backers of the UK investment trust to roll into a new fund, filings show.

CVC is the latest manager to seek out a large continuation fund for a Europe-headquartered asset, Secondaries Investor has learned.

One of the assets involved was being mulled for a separate CV managed Carlyle in a process that has since been dropped, Secondaries Investor understands.

Tikehau has raised more than €1bn for smart infrastructure company Egis.

Sports-focused foundation joins a number of APAC institutions seeking liquidity via the secondaries market this year.

The deal highlights GA’s ongoing use of CVs and ICG’s focus on single-asset transactions.

The firm wants to move around eight assets into a separate vehicle to extend their hold periods.